Efficacy of beta blockers in idiopathic dilated cardiomyopathy and ischemic cardiomyopathy

American Journal of Cardiology

Volumn 80, Issue 9 B, 1997, Pages

  Waagstein, Finn ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; BUCINDOLOL; METOPROLOL;

BETA ADRENERGIC RECEPTOR BLOCKING; CLINICAL TRIAL; CONFERENCE PAPER; CONGESTIVE CARDIOMYOPATHY; DRUG EFFICACY; DRUG SELECTIVITY; EXERCISE TOLERANCE; HUMAN; ISCHEMIC HEART DISEASE; MORBIDITY; PRIORITY JOURNAL; QUALITY OF LIFE; SURVIVAL;

EID: 0030668966     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(97)00839-4     Document Type: Conference Paper

References (60)

1. Waagstein F, Hjalmarson Å, Varnauskas E, Wallentin I. Effect of chronic beta-adrenergic receptor blockade in congestive cardiomyopathy. Br Heart J. 37:1975;1022-1036.
2. Tomita M, Spinale FG, Crawford FA, Zile MR. Changes in left ventricular volume, mass, and function during the development of supraventricular tachycardia-induced cardiomyopathy. Circulation. 83:1991;635-644.
3. Spinale FG, Tanaka R, Crawford FA, Zile MR. Changes in myocardial blood flow during development of and recovery from tachycardia-induced cardiomyopathy. Circulation. 85:1992;717-729.
4. Mulieri LA, Hasenfuss G, Leavitt B, Allen PD, Alpert NR. Altered myocardial force frequency relation in human heart failure. Circulation. 85:1992;1743-1750.
5. Mulieri LA, Leavitt B, Hasenfuss G, Allen PD, Alpert NR. Contraction frequency dependence of twitch and diastolic tension in human dilated cardiomyopathy (tension-frequency relation in cardiomyopathy) . Basic Res Cardiol. 87:1992;(suppl 1):199-(suppl 1):212.
6. Cohn JN, Levine TB, Olivari MT, Garberg V, Lura D, Francis GS, Simon AB, Rector T. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med. 311:1984;819-823.
7. Swedberg K, Eneroth P, Kjekshus J, Wilhelmsen L. Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. Circulation. 82:1990;1730-1736.
8. Massie B. Is neurohormonal activation deleterious for the long-term outcome of patients with congestive heart failure? J Am Coll Cardiol. 12:1988;547-558.
9. Chidsey CA, Braunwald E, Morrow AG. Catecholamine excretion and cardiac stores of norepinephrine in congestive heart failure. Am Med J. 39:1965;442-451.
10. Seferovic PM, Stepanovic S, Vasiljevic V, Ostojie M, Seferovic D, Maksimovic R, Marinkovic J, Simeunovic S, Simic D, Dangubic V, Ristic A. Dilated cardiomyopathy correlation between myocardial catecholamines, hemodynamics and long term survival. (Abstr.) . J Am Coll Cardiol. 23:(suppl):1994;148A.
11. Sievers R, Parmley WW, James T, Wikman-Coffelt J. Energy levels at systole vs diastole in normal hamster hearts vs myopathic hamster hearts. Circ Res. 53:1983;759-766.
12. i in quiescent ventricular myocardium. Cardiovasc Res. 28:1994;112-118.
13. 31P magnetic resonance spectroscopy in dilated cardiomyopathy and coronary artery disease altered cardiac high-energy phosphate metabolism in heart failure . Circulation. 86:1992;1810-1818.
14. Tsutsui H, Spinale FG, Nagatsu M, Schmid PG, Ishihara K, DeFreyte G, Cooper G IV, Carabello BA. Effects of chronic beta-adrenergic blockade on the left ventricular and cardiocyte abnormalities of chronic canine mitral regurgitation. J Clin Invest. 93:1994;2639-2648.
15. 2+ channel antagonists in an animal model of dilated cardiomyopathy. Circ Res. 73:1993;1077-1089.
16. Limas CJ, Goldenberg IF, Limas C. Influence of anti-beta-receptor antibodies on cardiac adenylate cyclase in patients with idiopathic dilated cardiomyopathy. Am Heart J. 119:1990;1322-1328.
17. 1-adrenergic receptor in patients with idiopathic dilated cardiomyopathy. J Clin Invest. 86:1990;1658-1663.
18. 1-adrenoceptor with positive chronotropic effect . Circulation. 89:1994;2760-2767.
19. Bristow MR, Ginsburg R, Minobe W, Cubicciotti RS, Sageman WS, Lurie K, Billingham ME, Harrison DC, Stinson EB. Decreased catecholamine sensitivity and beta-adrenergic receptor density in failing human hearts. N Engl J Med. 307:1982;205-211.
20. Asseman P, McFadden E, Bauchart JJ, Loubeyre C, Thery C. Why do beta-blockers help in idiopathic dilated cardiomyopathy-frequency mismatch? Lancet. 344:1994;803-804.
21. Liu C-P, Ting C-T, Lawrence W, Maughan L, Chang M-S, Kass DA. Diminished contractile response to increased heart rate in intact human left ventricular hypertrophy systolic versus diastolic determinants . Circulation. 88:1993;1893-1906.
22. Packer M, Carver JR, Rodeheffer RJ, Ivanhoe RJ, DiBianco R, Zeldis SM, Hendrix GH, Bommer WJ, Elkayam U, Kukin ML, Mallis GI, Sollano JA, Shannon J, Tandon PK, DeMeths DL. Effect of oral milrinone on mortality in severe chronic heart failure. N Engl J Med. 325:1991;1468-1475.
23. Schwartz A, Lindenmayer GE, Harigaya S. Respiratory control and calcium transport in heart mitochondria from the cardiomyopathic Syrian hamster. Trans NY Acad Sci. 30:(suppl 2):1968;951-954.
24. Anderson B, Hedner T, Blomström-Lundquist C, Waagstein F. Exercise hemodynamics and myocardial metabolism during long-term beta-adrenergic blockade in severe heart failure. J Am Coll Cardiol. 18:1991;1059-1066.
25. Eichhorn EJ, Heesch CM, Barnett JH, Alvarez LG, Fass SM, Grayburn PA, Hatfield BA, Marcoux LG, Malloy CR. Effect of metoprolol on function and energetics in patients with nonischemic dilated cardiomyopathy a randomized, double-blind, placebo-controlled study . J Am Coll Cardiol. 24:1994;1310-1320.
26. Maisel AS. Beneficial effects of metoprolol treatment in congestive heart failure reversal of sympathetic-induced alterations of immunologic function . Circulation. 90:1994;1774-1780.
27. 2+ transport in sarcoplasmic reticulum . Cardiovasc Res. 18:1984;371-376.
28. Matsui S, Fu MLX, Katsuda S, Hayase M, Yamaguchi N, Teraoka K, Kurihara T, Takekoshi N, Murakami E, Hoebeke J, Hjalmarson Å. Peptides derived from cardiovascular G-protein-coupled receptors induce morphological cardiomyopathic changes in immunized rabbit. J Mol Cell Cardiol. 29:1997;61-65.
29. Heilbrunn SM, Shah P, Bristow MR, Valantine HA, Ginsburg R, Fowler MB. Increased beta-receptor density and improved hemodynamic response to catecholamine stimulation during long-term metoprolol therapy in heart failure from dilated cardiomyopathy. Circulation. 79:1989;483-490.
30. Waagstein F, Caidahl K, Wallentin I, Bergh C-H, Hjalmarson Å. Long-term β-blockade in dilated cardiomyopathy effects of short- and long-term metoprolol treatment followed by withdrawal and readministration of metoprolol . Circulation. 80:1989;551-563.
31. Beau SL, Tolley TK, Saffitz JE. Heterogeneous transmural distribution of beta-adrenergic receptor subtypes in failing human hearts. Circulation. 88:1993;2501-2509.
32. Gilbert EM, Olsen SL, Renlund DG, Bristow MR. Beta-adrenergic receptor regulation and left ventricular function in idiopathic dilated cardiomyopathy. Am J Cardiol. 71:1993;23C-29C.
33. Waagstein F, Bristow MR, Swedberg K, Camerini F, Fowler MB, Silver MA, Gilbert EM, Johnson MR, Goss FG, Hjalmarson Å. Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy. Lancet. 342:1993;1441-1446.
34. Gilbert EM, Anderson JL, Deitchman D, Yanowitz FG, O'Connell JB, Renlund DG, Bartholomew M, Mealey PC, Larrabee P, Bristow MR. Long-term β-blocker vasodilator therapy improves cardiac function in idiopathic dilated cardiomyopathy a double blind, randomized study of bucindolol versus placebo . Am J Med. 88:1990;223-229.
35. Engelmeier RS, O'Connell JB, Walsh R, Rad N, Scanlon PJ, Gunnar R. Improvement in symptoms and exercise tolerance by metoprolol in patients with dilated cardiomyopathy a double-blind, randomized placebo-controlled trial . Circulation. 72:1985;536-546.
36. Bristow MR, O'Connell JB, Gilbert EM, French WJ, Leatherman G, Kantrowitz NE, Orie J, Smucker ML, Marshall G, Kelly P, Deitchman D, Anderson JL. Dose-response of chronic β-blocker treatment in heart failure from either idiopathic dilated or ischemic cardiomyopathy. Circulation. 89:1994;1632-1642.
37. Woodley SL, Gilbert EM, Anderson JL, O'Connell JB, Deitchman D, Yanowitz FG, Mealey PC, Volkman K, Renlund DG, Menlove R, Bristow MR. β-Blockade with bucindolol in heart failure caused by ischemic versus idiopathic dilated cardiomyopathy. Circulation. 84:1991;2426-2441.
38. Moe GW, Rouleau JL, Proulx G, Arnold M, Sestier F. Increased mortality with flosequinan in patients with failure is accompanied by increased plasma norepinephrine (Abstr.) . Circulation. 90:(suppl 1):1994;I-380.
39. Andersson B, Lomsky M, Waagstein F. The link between acute haemodynamic adrenergic beta-blockade and long-term effects in patients with heart failure a study on diastolic function, heart rate and myocardial metabolism following intravenous metoprolol . Eur Heart J. 14:1993;1375-1385.
40. Krum H, Schwartz B, Sackner-Bernstein J, Penn J, Goldsmith RL, Kukin ML, Medina N, Yushak M, Packer M. Double-blind, placebo-controlled study of the long-term efficacy of carvedilol in patients with severe heart failure treated with converting-enzyme inhibitors (Abstr.) . J Am Coll Cardiol. 21:(suppl A):1993;114A.
41. Rahman MA, Hara K, Senn BM, Daly PA, Wigle ED, Floras JS. Reductions in muscle sympathetic nerve activity after chronic β-blockade for dilated cardiomyopathy (Abstr.) . Circulation. 88:(suppl 1):1993;I-415.
42. Waagstein F. Adrenergic beta-blocker agents in congestive heart failure due to idiopathic dilated cardiomyopathy. Eur Heart J. 16:(suppl O):1995;128-132.
43. A randomized trial of beta-blockade in heart failure the Cardiac Insufficiency Bisoprolol Study (CIBIS) . Circulation. 90:1994;1765-1773.
44. Packer M, Bristow MR, Cohn JN, Colucci WS, Fowler MB, Gilbert EM, Shusterman NH. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med. 334:1996;1349-1355.
45. Effects of carvedilol, a vasodilator-β-blocker, in patients with congestive heart failure due to ischemic heart disease. Circulation. 92:1995;212-218.
46. Ikram H, Chan W, Bennet SI, Bones PJ. Hemodynamic effects of acute beta-adrenergic receptor blockade in congestive cardiomyopathy. Br Heart J. 42:1979;311-315.
47. DasGupta P, Broadhurst P, Lahiri A. The effects of intravenous carvedilol, a new multiple action vasodilatory beta-blocker, in congestive heart failure. J Cardiovasc Pharmacol. 18:(suppl 4):1991;S12-S16.
48. Swedberg K, Hjalmarson Å, Waagstein F, Wallentin I. Beneficial effects of long-term beta-blockade in congestive cardiomyopathy. Br Heart J. 44:1980;117-133.
49. Wisenbaugh T, Katz I, Davis J, Essop R, Skoularigis J, Middlemost S, Röthlisberger C, Skudiky D, Sareli P. Long-term (3-month) effects of a new beta-blocker (nebivolol) on cardiac performance in patients with dilated cardiomyopathy. J Am Coll Cardiol. 21:1993;1094-1100.
50. Anderson JL, Lutz JR, Gilbert EM, Sorensen SG, Yanowitz FG, Menlove RL, Bartholomew M. A randomized trial of low-dose beta-blockade therapy for idiopathic dilated cardiomyopathy. Am J Cardiol. 55:1985;471-475.
51. Leung W-H, Lau C-P, Wong C-K, Cheng C-H, Tai Y-T, Lim S-P. Improvement in exercise performance and hemodynamics by labetalol in patients with dilated cardiomyopathy. Am Heart J. 119:1990;884-890.
52. Pollock SG, Lystash J, Tedesco C, Craddock G, Smucker ML. Usefulness of bucindolol in congestive heart failure. Am J Cardiol. 66:1990;603-607.
53. Fisher ML, Gottlieb SS, Plotnick GD, Greenberg NL, Patten RD, Bennett SK, Hamilton BP. Beneficial effects of metoprolol in heart failure associated with coronary artery disease a randomized trial . J Am Coll Cardiol. 23:1994;943-950.
54. Andersson B, Caidahl K, diLenarda A, Warren SE, Goss F, Waldenström A, Persson S, Wallentin I, Hjalmarson Å, Waagstein F. Changes in early and late diastolic filling patterns induced by long-term adrenergic beta-blockade in patients with idiopathic dilated cardiomyopathy. Circulation. 94:1996;673-682.
55. Andersson B, Hamm C, Persson S, Wikström G, Sinagra G, Hjalmarson Å, Waagstein F. Improved exercise hemodynamic status in dilated cardiomyopathy after beta-adrenergic blockade treatment. J Am Coll Cardiol. 23:1994;1397-1404.
56. Waagstein F. Cost-effectiveness of metoprolol in idiopathic dilated cardiomyopathy (Abstr.) . J Am Coll Cardiol. 29:(suppl A):1996;325A.
57. Lindelöw B, Andersson B, Waagstein F, Bergh C-H. Prognosis of alternative therapies in heart failure patients not accepted for heart transplantation. J Heart Lung Transplant. 14:1995;1204-1211.
58. Chadda K, Goldstein S, Byington R, Curb JD. Effect of propranolol after acute myocardial infarction in patients with congestive heart failure. Circulation. 73:1986;503-510.
59. Herlitz J, Hjalmarson Å, Waagstein F. Effect of metoprolol among patients with suspected acute myocardial infarction and left ventricular dysfunction (Abstr.) . Eur Heart J. 17:(abstr suppl):1996;514.
60. Guidelines the treatment of heart failure . Eur Heart J. 18:1997;736-753.